Research ArticleNEUROPHARMACOLOGY
Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma
Tiziana Genovese, Emanuela Mazzon, Carmelo Muià, Nimesh S. A. Patel, Michael D. Threadgill, Placido Bramanti, Angelina De Sarro, Christoph Thiemermann and Salvatore Cuzzocrea
Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 449-457; DOI: https://doi.org/10.1124/jpet.104.076711
Tiziana Genovese
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Emanuela Mazzon
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Carmelo Muià
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Nimesh S. A. Patel
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Michael D. Threadgill
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Placido Bramanti
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Angelina De Sarro
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Christoph Thiemermann
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
Salvatore Cuzzocrea
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy (T.G., E.M., C.M., A.D., S.C.); Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary-University of London, London, United Kingdom (N.S.A.P., C.T.); Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom (M.D.T.); and Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, School of Medicine, University of Messina, Messina, Italy (P.B.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleNEUROPHARMACOLOGY
Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma
Tiziana Genovese, Emanuela Mazzon, Carmelo Muià, Nimesh S. A. Patel, Michael D. Threadgill, Placido Bramanti, Angelina De Sarro, Christoph Thiemermann and Salvatore Cuzzocrea
Journal of Pharmacology and Experimental Therapeutics February 1, 2005, 312 (2) 449-457; DOI: https://doi.org/10.1124/jpet.104.076711
Research ArticleNEUROPHARMACOLOGY
Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma
Tiziana Genovese, Emanuela Mazzon, Carmelo Muià, Nimesh S. A. Patel, Michael D. Threadgill, Placido Bramanti, Angelina De Sarro, Christoph Thiemermann and Salvatore Cuzzocrea
Journal of Pharmacology and Experimental Therapeutics February 1, 2005, 312 (2) 449-457; DOI: https://doi.org/10.1124/jpet.104.076711
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement